Fate Therapeutics Inc Asset Turnover Ratio (FATE), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Fate Therapeutics Inc   (NASDAQ: FATE)
 

Fate Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Fate Therapeutics Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.02 in the first quarter (Mar 31 2026)

Within sector 63 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 2117 to 3651.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FATE Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change -28.64 % -27.5 % -30.54 % -29.77 % -29.96 %
Y / Y Revenue Change -20.26 % -26.4 % -43.36 % -71.84 % -15.38 %
Asset Turnover Ratio (TTM) 0.02 0.02 0.02 0.02 0.03
FATE's Total Ranking # 3651 # 2117 # 2294 # 3119 # 2836
Seq. Asset Change -11.08 % -6.87 % -7.42 % -6.93 % -9.66 %
Seq. Revenue Change -5.11 % -21.37 % -8.7 % 17.07 % -12.42 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 64
Healthcare Sector # 527
Overall Market # 3651

Asset Turnover Ratio Statistics
High Average Low
0.19 0.06 0.01
(Mar 31 2023)   (Mar 31 2024)




FATE Company Profile • Back to FATE Efficiency Comparisons • Compare FATE Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Caribou Biosciences Inc   0.06 $ 11.203  Millions$ 185.063  Millions
Alector Inc   0.06 $ 18.417  Millions$ 306.215  Millions
Prophase Labs Inc   0.06 $ 3.386  Millions$ 56.586  Millions
Abcellera Biologics Inc   0.06 $ 79.208  Millions$ 1,355.529  Millions
Grail Inc   0.06 $ 156.120  Millions$ 2,757.268  Millions
Nexalin Technology Inc   0.06 $ 0.276  Millions$ 5.005  Millions
Kyntra Bio Inc   0.05 $ 7.439  Millions$ 136.073  Millions
Agios Pharmaceuticals Inc   0.05 $ 66.048  Millions$ 1,334.789  Millions
Insight Molecular Diagnostics Inc   0.05 $ 1.949  Millions$ 40.159  Millions
Recursion Pharmaceuticals Inc   0.05 $ 66.408  Millions$ 1,378.883  Millions
Seer Inc   0.05 $ 14.386  Millions$ 299.828  Millions
Aligos Therapeutics Inc   0.05 $ 4.705  Millions$ 99.390  Millions
Astrotech Corp  0.05 $ 1.008  Millions$ 21.525  Millions
Aclaris Therapeutics Inc   0.05 $ 8.367  Millions$ 180.965  Millions
Camp4 Therapeutics Corporation  0.04 $ 3.934  Millions$ 90.234  Millions
X4 Pharmaceuticals Inc  0.04 $ 9.014  Millions$ 207.366  Millions
Catheter Precision Inc   0.04 $ 1.108  Millions$ 25.495  Millions
Instil Bio Inc   0.04 $ 8.968  Millions$ 211.676  Millions
EBR Systems, Inc.  0.04 $ 3.979  Millions$ 99.358  Millions
Solana Company  0.04 $ 9.589  Millions$ 247.113  Millions
Mountain Crest Acquisition Corp V  0.04 $ 0.041  Millions$ 1.101  Millions
Blue Water Vaccines Inc  0.04 $ 0.735  Millions$ 19.639  Millions
Tscan Therapeutics Inc   0.04 $ 9.136  Millions$ 247.892  Millions
Kymera Therapeutics Inc   0.04 $ 51.476  Millions$ 1,411.235  Millions
Pluri Inc   0.03 $ 1.079  Millions$ 32.252  Millions
Vivos Inc  0.03 $ 0.078  Millions$ 2.472  Millions
Bioage Labs Inc   0.03 $ 10.316  Millions$ 329.945  Millions
Newamsterdam Pharma Company N v   0.03 $ 22.565  Millions$ 775.867  Millions
Tao Synergies Inc   0.03 $ 0.688  Millions$ 23.758  Millions
Dbv Technologies S a   0.03 $ 5.783  Millions$ 209.755  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.